COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,556 Articles (22,400 medRxiv, 8,156 bioRxiv)

Most recent first Previous |  Page 2597: Articles 25961-25970  | Next

Clinical features of COVID-19 patients in Abdul Wahab Sjahranie Hospital, Samarinda, Indonesia
Paramita, S., Isnuwardana, R., Marwan, M., Alfian, D. I., Masjhoer, D. H.
10.1101/2020.05.27.20114348 — Posted: 2020-06-02
Prevalence of SARS-CoV-2 Antibodies Among Healthcare Workers at a Tertiary Academic Hospital in New York City
Mansour, M., Levin, E., Muellers, K., Stone, K., Mendu, R., Wajnberg, A.
10.1101/2020.05.27.20090811 — Posted: 2020-06-02 Discussion: Offsite
Rapid Epidemiological Analysis of Comorbidities andTreatments as risk factors for COVID-19 in Scotland(REACT-SCOT): a population-based case-control study
McKeigue, P. M., Weir, A., Bishop, J., McGurnaghan, S., Kennedy, S., McAllister, D., Robertson, C., Wood, R., Lone, N., Murray, J., Caparrotta, T., Smith-Palmer, A., Goldberg, D., McMenamin, J., Ramsay, C., Hutchinson, S., Colhoun, H. M.
10.1101/2020.05.28.20115394 — Posted: 2020-06-02 Discussion: Onsite
Estimated Sp02/Fio2 ratio to predict mortality in patients with suspected COVID-19 in the Emergency Department: a prospective cohort study
von Vopelius-Feldt, J., Watson, D., Swanson-Low, C., Cameron, J.
10.1101/2020.05.28.20116194 — Posted: 2020-06-02
Early CPAP reduced mortality in covid-19 patients. Audit results from Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust.
Ashish, A., Unsworth, A., Martindale, J., Sundar, R., Sedda, L., Farrier, M.
10.1101/2020.05.28.20116152 — Posted: 2020-06-02
The COVID-19 Critical Care Consortium observational study: Design and rationale of a prospective, international, multicenter, observational study
Li Bassi, G., Suen, J., Barnett, A. G., Corley, A., Millar, J. E., Fanning, J. P., Lye, I., Colombo, S., Wildi, K., Livingstone, S., Abbate, G., Hinton, S., Liquet, B., Shrapnel, S., Dalton, H. J., Fraser, J. F.
10.1101/2020.05.29.20115253 — Posted: 2020-06-02
G6PD variant distribution in sub-Saharan Africa and potential risks ofusing chloroquine/hydroxychloroquine based treatments forCOVID-19
da Rocha, J., Othman, H., Tiemessen, C. T., Botha, G., Ramsay, M., Masimirembwa, C., Adebamowo, C., Choudhury, A., Brandenburg, J.-T., Matshaba, M., Simo, G., Gamo, F.-J., Hazelhurst, S.
10.1101/2020.05.27.20114066 — Posted: 2020-06-02
Exhaled breath is a significant source of SARS-CoV-2 emission
Ma, J., Qi, X., Chen, H., Li, X., Zhan, Z., Wang, H., Sun, L., Zhang, L., Guo, J., Morawska, L., Grinshpun, S. A., Biswas, P., Flagan, R. C., Yao, M.
10.1101/2020.05.31.20115154 — Posted: 2020-06-02 Discussion: Onsite
Immunochromatographic assays for COVID-19 epidemiological screening: our experience
Bartolini, A., Scapaticci, M., Bioli, M., Lazzarotto, T., Re, M. C., Mancini, R.
10.1101/2020.05.28.20116046 — Posted: 2020-06-02
The Risk of Lifting COVID-19 Confinement in Mexico
Azanza Ricardo, C. L., Hernandez Vargas, E. A.
10.1101/2020.05.28.20115063 — Posted: 2020-06-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).